Bid price | 120.00 | Open price | 118.00 |
---|---|---|---|
Ask price | 122.00 | Prev close | 120.00 |
High price | 0.00 | Spread | 1.64% |
Low price | 0.00 | Volume | 0 |
Register now for FREE live Synairgen share prices, Synairgen stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Synairgen Level 2 Data, indepth research tools and investor commentary for Synairgen (SNG) and other London Stock Exchange equities.
Register now for FREE Synairgen share price charts
Name | Synairgen | Epic | SNG |
---|---|---|---|
Sector | n/a | ISIN | GB00B0381Z20 |
Activites | n/a | Index | n/a |
Dec.Date | Type | Director | Pos | No. of Shares |
---|---|---|---|---|
19/08/2021 | SEXR | Richard Marsden | CEO | 296,959 |
19/08/2021 | EXR | Richard Marsden | CEO | 538,063 |
19/08/2021 | SEXR | Phillip Monk | RES | 220,878 |
19/08/2021 | EXR | Phillip Monk | RES | 400,212 |
19/08/2021 | SEXR | John Ward | RES | 269,963 |
RNS Number : 3364F Synairgen plc 13 November 2020 Synairgen plc ("Synairgen" or the "Company") Holding(s) in Company Southampton, UK , : Synairgen plc (LSE: SNG), the...
RNS Number : 1994F Synairgen plc 13 November 2020 Press release Synairgen plc ('Synairgen' or the 'Company') Data from SG016 Phase II Clinical Trial published in...
RNS Number : 8725E Synairgen plc 10 November 2020 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR...
More Synairgen Company News >>
Register now for FREE Synairgen company news
Synairgen is a drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic. The business, focused primarily on severe asthma and COPD, uses its differentiating human biology BioBank platform and world-renowned...
Register now for FREE Synairgen share price discussions